Category Diagnostics
Prolocor(R) Announces Publication in Circulation: Cardiovascular Interventions. Results Demonstrate That the Prolocor pFCG(TM) Test Predicts Risk of Subsequent Cardiovascular Events Regardless of Treatment Strategy (Percutaneous Coronary Intervention or Medical Management Alone)
Despite differences in characteristics and treatment, the pFCG test distinguished risk of the primary ischemic endpoint to a similar extent in the 2 groups.
No significant association was observed between pFCG and risk of bleeding.
Prolocor to Present New Clinical Evidence at ACC 25 Supporting Use of PLATELET FCɣRIIA (PFCG) As Key Tool In Individualizing Dual Antiplatelet Therapy (DAPT)
Date: March 31, 2025, 10:36 A.M.
Location: Moderated Poster Theater 7
PROGNOSTIC IMPLICATIONS OF PLATELET FCɣRIIA DURING THE FIRST YEAR AFTER MYOCARDIAL INFARCTION
Read More
TridentCare and Essence Healthcare Partner to Expand Portable Diagnostic Services to Medicare Advantage Beneficiaries
New partnership will deliver convenient, at-home X-ray and ultrasound services to over 60,000 Medicare Advantage members in Illinois, Missouri, Ohio, Kentucky and Indiana
Read More
Liom Cracks "Holy Grail" of Non-Invasive Glucose Monitoring and Secures USD >25m in Funding Kickstarting Its Series A
Liom, formerly known as Spiden, a pioneer in non-invasive biomarker monitoring aiming to develop the first non-invasive glucose monitoring wearable, is thrilled to announce significant technological milestones and a successful kick-off of its Series A.
Read More
FDA Clears 'Selux NGP System' for Rapid Antibiotic Susceptibility Testing
In vitro antimicrobial resistance test enables clinical labs to deliver targeted therapeutic results days faster than the current standard of care, clearing the path for personalized antibiotic therapies Read More
BioNTech Establishes Asia-Pacific Clinical Scale mRNA Manufacturing & Regional Research Centre
German-based biotechnology company BioNTech will establish a clinical scale research mRNA manufacturing facility in Australia, following an in-principle letter of intent signed with the Victorian Government. Read More
Senzo's Revolutionary Amplified Lateral Flow (ALF) Platform Delivers Rapid COVID-19 Test Exactly Matching PCR Results in 3rd-Party Study by the University of Sheffield
World's first amplified lateral flow rapid test combines the accuracy and early detection of central lab testing with the simplicity, speed, and low cost of traditional lateral flow tests Read More
